Why the study?
Guidelines recommend indefinite oral anticoagulation for AF patients with stroke risk factors regardless of catheter ablation outcomes based largely on non-randomized evidence, leaving the long-term anticoagulation strategy after successful ablation uncertain.
Does discontinuation of oral anticoagulation prevent bleeding without increasing thromboembolic events in patients with atrial fibrillation after successful catheter ablation?
Population
2,324 patients across 3 RCTs after successful catheter ablation for AF
Comparison
Discontinuing OAC vs continuing OAC
Design
Meta-analysis of randomized controlled trials
Key result
No clinical findings are available as the provided text consists only of the journal's editorial board information.
Authors
Loading...
May support OAC discontinuation after successful ablation; challenges guideline recommendations based on non-randomized data.
Meta-Analysis
Does discontinuation of oral anticoagulation prevent bleeding without increasing thromboembolic events in patients with atrial fibrillation after successful catheter ablation?
Discontinuing oral anticoagulation after successful catheter ablation for atrial fibrillation may safely reduce bleeding risks without increasing thromboembolic events, challenging current guidelines.
Kaisaier et al. (2026) conducted a meta-analysis in Atrial Fibrillation. Discontinuation of Oral Anticoagulation was evaluated. No clinical findings are available as the provided text consists only of the journal's editorial board information.